Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-21-000041

Director sold 6,000 shares at $385.08 ($2,310,481)

  • Director acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Nusse Roeland · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-08 Exercise or conversion : show line 1 in the form +1,000 $70.35 $70,350 7,765 D
2021-02-08 Exercise or conversion : show line 2 in the form +5,000 $66.90 $334,500 12,765 D
2021-02-08 Sale : show line 3 in the form −6,000 $385.08 $2,310,481 6,765 D
Open-market sales · 6,000 sh · avg $385.08 · $2,310,481

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-02-08 Exercise or conversion : show line 4 in the form Stock Option (right to buy) −1,000 4,000 D
2021-02-08 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −5,000 0 D
Loading xslF345X03/edgar.xml…